The Institute for Neurological Research® in Los Angeles and Newport Beach

INR 100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California 90095 (310) 824-6199 Edward Tobinick MD, Medical Director

New Orange County office: 361 Hospital Road, Suite 428 Newport Beach, California 92663

Rapid improvement in Alzheimer's, beginning within minutes*

Video1 Video2 Video3 Video4 Video5 Video6 Video7 Video8 Video9 Video10 Video11 Video12

*see: Edward Tobinick MD, Perispinal etanercept for neuroinflammatory disorders Drug Discovery Today 2009 Feb;14(3-4):168-77. (download abstracts PDF)

Perispinal etanercept for Alzheimer's is a patented[1], off-label treatment method invented at the INR. It is available in the U.S. exclusively through INR trained and licensed physicians. Patients and physicians are coming to the INR from around the world for treatment and physician training.

as seen in Nature Clinical Practice Neurology, in a university press release, on Medscape, the BBC, New Scientist, CNN, Fox News, ABC News, Bloomberg News, Reuters Health, the Times Online (U.K.), the Daily Telegraph(U.K.), and UPI.

Appointments and information (310) 824-6199

In the News: Epidural etanercept for lumbosacral radiculopathy, an off-label treatment method invented at the INR, has positive results in randomized, double-blind, placebo-controlled clinical trial conducted at Walter Reed Army Medical Center (link)

Upcoming international conference presentations by Edward Tobinick MD, Director of the INR:

TNF Modulation for treatment of Alzheimer's Disease, at the Targeting Alzheimer's with Novel Therapeutics Conference at the World Pharmaceutical Congress, Philadelphia, June 11, 2009 (more information)

<Map and Directions><Appointments><Physician Training Program><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Videos>

Copyright ©2009, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. [1]U.S. patents 6,537,549; 6,982,089; 7,214,658; and Australian patent 758,523; and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Please see the medical and legal disclaimer.